ArticleIBRO neuroscience reports2024

Effects silymarin and rosuvastatin on amyloid-carriers level in dyslipidemic Alzheimer's patients: A double-blind placebo-controlled randomized clinical trial.

Auob Rustamzadeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.